Press Releases Ypsomed Group

Burgdorf – The Ypsomed Group will also be securing its position as a technology leader in the field of injection and infusion systems well into the future.

Press Releases Ypsomed Group

Burgdorf – Ypsomed increases EBIT margin in double digits and raises the forecast for the business year 2015/16 clearly.

Press Releases Ypsomed Group

Burgdorf – Hanmi Pharmaceutical Co., Ltd. has three biotechnology proteins in its project portfolio that are in various stages of development and approval. Ypsomed signs comprehensive master agreement with the South Korean Hanmi Pharmaceutical Co., Ltd. for pen systems and autoinjectors for three long-acting biologics.

Press Releases Ypsomed Group

Burgdorf – For the 2014/15 fiscal year, a dividend of CHF 0.60 per share, exempt from withholding tax, will be paid to shareholders from capital reserves.

Press Releases Ypsomed Group

Burgdorf – Ypsomed now supplies the Polish company Polfa Tarchomin S. A. with its reusable and affordable YpsoPen. The YpsoPen is being introduced to the Polish market and will be used to administer Polfa Tarchomin's insulin. Negotiations are in place to expand cooperation to other countries.